Tumor Lysis Syndrome Induced by Sorafenib in a Patient With Hepatocellular Carcinoma: Literature Review and a Case Report

被引:0
|
作者
Chou, Jen-Wei [1 ]
Cheng, Ken-Sheng [1 ]
Akella, Trupti [2 ]
Lee, Chi Chan [3 ]
Ju, Teressa R. [4 ]
机构
[1] China Med Univ Hosp, Taichung, Taiwan
[2] Aventura Hosp & Med Ctr, Aventura, FL USA
[3] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[4] Mackay Mem Hosp, Taipei, Taiwan
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2858
引用
收藏
页码:S1582 / S1583
页数:2
相关论文
共 50 条
  • [1] Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient
    Wu-Shiung Huang
    Chang-Hsu Yang
    World Journal of Gastroenterology, 2009, 15 (35) : 4464 - 4466
  • [2] Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient
    Huang, Wu-Shiung
    Yang, Chang-Hsu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (35) : 4464 - 4466
  • [3] Tumor Lysis Syndrome after Sorafenib for Hepatocellular Carcinoma: a Case Report
    Shiozawa, Kazue
    Watanabe, Manabu
    Takenaka, Hiroki
    Nagai, Hidenari
    Ishii, Koji
    Sakai, Ken
    Sumino, Yasukiyo
    HEPATO-GASTROENTEROLOGY, 2010, 57 (101) : 688 - 690
  • [4] Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case report
    Shimizu, Yoshiaki
    Sunagozaka, Hajime
    Yamagata, Koki
    Hirai, Hirokazu
    Miura, Miyabi
    Yonemoto, Yuichiro
    Naito, Yoshihide
    Hasatani, Kenkei
    Yoshikawa, Jun
    Aoyagi, Hiroyuki
    Kaneko, Shuichi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (02) : 645 - 649
  • [5] Lenvatinib-induced tumor lysis syndrome in a patient with advanced hepatocellular carcinoma: a case report
    Yoshiaki Shimizu
    Hajime Sunagozaka
    Koki Yamagata
    Hirokazu Hirai
    Miyabi Miura
    Yuichiro Yonemoto
    Yoshihide Naito
    Kenkei Hasatani
    Jun Yoshikawa
    Hiroyuki Aoyagi
    Shuichi Kaneko
    Clinical Journal of Gastroenterology, 2021, 14 : 645 - 649
  • [6] Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma
    Kudo, Chieko
    Miura, Masahito
    Gamoh, Makio
    Niitani, Tomohito
    Tamagawa, Hiroki
    Takahashi, Kiichi
    Ichikawa, Sonoko
    Sugiyama, Katsuo
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2015, 4 (03): : 147 - 150
  • [7] Tumor lysis syndrome after treatment with sorafenib for hepatocellular carcinoma
    Chieko Kudo
    Masahito Miura
    Makio Gamoh
    Tomohito Niitani
    Hiroki Tamagawa
    Kiichi Takahashi
    Sonoko Ichikawa
    Katsuo Sugiyama
    International Cancer Conference Journal, 2015, 4 (3) : 147 - 150
  • [8] A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
    Joshita, Satoru
    Yoshizawa, Kaname
    Sano, Kenji
    Kobayashi, Satoshi
    Sekiguchi, Tomohiro
    Morita, Susumu
    Kamijo, Atsushi
    Komatsu, Michiharu
    Umemura, Takeji
    Ichijo, Tetsuya
    Matsumoto, Akihiro
    Tanaka, Eiji
    INTERNAL MEDICINE, 2010, 49 (11) : 991 - 994
  • [9] Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: Case reports and literature review
    Pei-Min Hsieh
    Kao-Chen Hung
    Yaw-Sen Chen
    World Journal of Gastroenterology, 2009, 15 (37) : 4726 - 4728
  • [10] Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: Case reports and literature review
    Hsieh, Pei-Min
    Hung, Kao-Chen
    Chen, Yaw-Sen
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (37) : 4726 - 4728